Addus HomeCare (NASDAQ:ADUS) Upgraded by StockNews.com to “Strong-Buy”

StockNews.com upgraded shares of Addus HomeCare (NASDAQ:ADUSFree Report) from a buy rating to a strong-buy rating in a research report released on Saturday morning.

A number of other brokerages have also issued reports on ADUS. Macquarie began coverage on shares of Addus HomeCare in a research report on Friday. They issued an outperform rating and a $136.00 target price for the company. Barclays lowered shares of Addus HomeCare from an equal weight rating to an underweight rating and set a $83.00 target price for the company. in a research report on Tuesday, April 23rd. TD Cowen increased their target price on shares of Addus HomeCare from $119.00 to $128.00 and gave the company a buy rating in a research report on Tuesday, June 18th. Bank of America increased their target price on shares of Addus HomeCare from $115.00 to $118.00 and gave the company a buy rating in a research report on Tuesday, May 7th. Finally, Oppenheimer increased their target price on shares of Addus HomeCare from $118.00 to $130.00 and gave the company an outperform rating in a research report on Friday, June 7th. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of Moderate Buy and an average price target of $116.25.

Get Our Latest Stock Report on ADUS

Addus HomeCare Stock Up 1.7 %

ADUS stock opened at $116.11 on Friday. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14. Addus HomeCare has a fifty-two week low of $78.35 and a fifty-two week high of $120.53. The firm’s 50-day simple moving average is $109.70 and its 200 day simple moving average is $99.95. The stock has a market cap of $1.90 billion, a PE ratio of 28.81, a price-to-earnings-growth ratio of 1.75 and a beta of 1.02.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The business had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. During the same quarter last year, the company earned $0.84 EPS. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year. As a group, sell-side analysts predict that Addus HomeCare will post 4.36 EPS for the current year.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 4.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Principal Securities Inc. purchased a new position in shares of Addus HomeCare in the fourth quarter worth approximately $26,000. GAMMA Investing LLC acquired a new stake in shares of Addus HomeCare during the fourth quarter worth approximately $34,000. EntryPoint Capital LLC acquired a new stake in shares of Addus HomeCare during the first quarter worth approximately $44,000. Assetmark Inc. boosted its holdings in shares of Addus HomeCare by 33.3% during the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after purchasing an additional 443 shares during the period. Finally, Envestnet Portfolio Solutions Inc. acquired a new stake in shares of Addus HomeCare during the fourth quarter worth approximately $214,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.